{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:40:39Z","timestamp":1790635239151,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tumour Virus Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.tvr.2022.200250","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T02:59:27Z","timestamp":1674183567000},"page":"200250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Unresolved issues in the management of human papillomavirus-associated mucosal high-grade pre-cancers"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9250-2638","authenticated-orcid":false,"given":"Charles JN.","family":"Lacey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvr.2022.200250_bib1","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1073\/pnas.80.12.3812","article-title":"A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions","volume":"80","author":"D\u00fcrst","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tvr.2022.200250_bib2","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.tvr.2022.200250_bib3","series-title":"Cancer of the Uterus: Harveian Lectures for 1886","author":"Williams","year":"1888"},{"key":"10.1016\/j.tvr.2022.200250_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/BF01725182","article-title":"Histologische untersuchungen uber atypisches plattenepithel an der portio und an der inneflache der cervix uteri","volume":"85","author":"Schauenstein","year":"1908","journal-title":"Arch. Gynekol."},{"key":"10.1016\/j.tvr.2022.200250_bib5","first-page":"210","article-title":"Early diagnosis of carcinoma of the cervix","volume":"56","author":"Schiller","year":"1933","journal-title":"Surg. Gynecol. Obstet."},{"key":"10.1016\/j.tvr.2022.200250_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/jama.1952.02930250026009","article-title":"Clinical relationship of carcinoma in situ and invasive carcinoma of the cervix","volume":"149","author":"Galvin","year":"1952","journal-title":"JAMA"},{"key":"10.1016\/j.tvr.2022.200250_bib7","first-page":"821","article-title":"Evolution et traitement des epitheliomas","volume":"56","author":"Kottmeier","year":"1961","journal-title":"Rev Fran Gynecol d'Obstet"},{"key":"10.1016\/j.tvr.2022.200250_bib8","first-page":"451","article-title":"The invasive potential of carcinoma in situ of the cervix","volume":"64","author":"McIndoe","year":"1984","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.tvr.2022.200250_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1097-0142(1955)8:1<42::AID-CNCR2820080105>3.0.CO;2-H","article-title":"Atypical hyperplasia of uterine cervix","volume":"8","author":"Reagan","year":"1955","journal-title":"Cancer"},{"key":"10.1016\/j.tvr.2022.200250_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0002-9378(16)37837-1","article-title":"The significance of basal-cell hyperactivity in cervical biopsies","volume":"70","author":"Galvin","year":"1955","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.tvr.2022.200250_bib11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00003081-196712000-00002","article-title":"Natural history of cervical intraepithelial neoplasia","volume":"10","author":"Richart","year":"1967","journal-title":"Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.tvr.2022.200250_bib12","first-page":"131","article-title":"A modified terminology for cervical intraepithelial neoplasia","volume":"75","author":"Richart","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.tvr.2022.200250_bib13","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199210293271804","article-title":"A cohort study of the risk of cervical intraepithelial neoplasia garde 2 or 3 in relation to papillomavirus infection","volume":"327","author":"Koutsky","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tvr.2022.200250_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(98)12490-X","article-title":"Relation of human papillomavirus to cervical lesions and consequences for cervical-cancer screening: a prospective study","volume":"354","author":"Nobbenhuis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.tvr.2022.200250_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/bjc.1989.236","article-title":"Natural history of cervical neoplasia: consistent results obtained by an identification technique","volume":"60","author":"Gustafsson","year":"1989","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tvr.2022.200250_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/bjc.1991.350","article-title":"Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer","volume":"64","author":"Van Oortmarssen","year":"1991","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tvr.2022.200250_bib17","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0140-6736(01)06809-X","article-title":"Cytological regression of high-risk human papillomavirus in women with an abnormal smear","volume":"358","author":"Nobbenhuis","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.tvr.2022.200250_bib18","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0140-6736(00)03315-8","article-title":"Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7","volume":"356","author":"Hopfl","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.tvr.2022.200250_bib19","first-page":"257","article-title":"Premalignant conditions of the cervix","volume":"vol. 3","author":"Burghardt","year":"1976"},{"key":"10.1016\/j.tvr.2022.200250_bib20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1471-0528.1989.tb03381.x","article-title":"Cytological status and lesion size: a further dimension in cervical intraepithelial neoplasia","volume":"96","author":"Jarmulowicz","year":"1989","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.tvr.2022.200250_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1471-0528.1992.tb13825.x","article-title":"CIN 3: the role of lesion size in invasion","volume":"99","author":"Tidbury","year":"1992","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.tvr.2022.200250_bib22","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1099\/0022-1317-78-5-1095","article-title":"The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions","volume":"78","author":"Daniel","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.tvr.2022.200250_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pvr.2016.04.003","article-title":"Molecular events leading to HPV-induced high-grade neoplasia","volume":"2","author":"Wilting","year":"2016","journal-title":"Papillomavirus Res."},{"key":"10.1016\/j.tvr.2022.200250_bib24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciaa166","article-title":"On behalf of the study of prevention of anal cancer study team. The natural history of anal high-grade squamous intraepithelial lesions in gay and bisexual men","volume":"72","author":"Poynten","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tvr.2022.200250_bib25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1471-0528.1989.tb03380.x","article-title":"Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intraepithelial neoplasia","volume":"96","author":"Prendiville","year":"1989","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.tvr.2022.200250_bib26","article-title":"Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up","volume":"97","author":"Lili","year":"2018","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.tvr.2022.200250_bib27","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","volume":"11","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tvr.2022.200250_bib28","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","article-title":"Treatment of anal high-grade squamous Intraepithelial lesions to prevent anal cancer","volume":"386","author":"Palefsky","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tvr.2022.200250_bib29","author":"Lacey"},{"key":"10.1016\/j.tvr.2022.200250_bib30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF01736652","article-title":"Versuche uber Immunotherapie der Warzen und Kondylome","volume":"4","author":"Biberstein","year":"1925","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.tvr.2022.200250_bib31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1099\/0022-1317-74-6-945","article-title":"Prophylactic and therapeutic vaccination against a mucosal papillomavirus","volume":"74","author":"Campo","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.tvr.2022.200250_bib32","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1080\/21645515.2020.1823778","article-title":"Durability of response to VGX-3100 treatment of HPV16\/18 positive cervical HSIL","volume":"17","author":"Bhuyan","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.tvr.2022.200250_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55014-z","article-title":"A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteins","volume":"9","author":"Hancock","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tvr.2022.200250_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.antiviral.2017.12.013","article-title":"Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures","volume":"150","author":"Banerjee","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.tvr.2022.200250_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009216","article-title":"MEK\/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors","volume":"17","author":"Luna","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tvr.2022.200250_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2012.06.028","article-title":"Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva","volume":"127","author":"Horowitz","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.tvr.2022.200250_bib37","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.21.02433","article-title":"Clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4\/miR124-2 DNA methylation (CONCERVE study)","author":"Kremer","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tvr.2022.200250_bib38","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/cid\/ciz677","article-title":"Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia","volume":"70","author":"Louvanto","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tvr.2022.200250_bib41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/CJI.0000000000000414","article-title":"Topical imiquimod treatment of high-grade cervical intraepithelial neoplasia (TOPIC-3): a nonrandomized multicenter study","volume":"45","author":"Hendriks","year":"2022","journal-title":"J. Immunother."},{"key":"10.1016\/j.tvr.2022.200250_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2022.01.033","article-title":"Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: multicenter, randomized controlled trial","volume":"165","author":"Polterauer","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.tvr.2022.200250_bib43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/aogs.14359","article-title":"Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: a systematic review and meta-analysis","volume":"101","author":"Eriksen","year":"2022","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.tvr.2022.200250_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070135","article-title":"Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis","volume":"378","author":"Kechagias","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.tvr.2022.200250_bib45","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/j.vaccine.2017.12.079","article-title":"Explanations for the high potency of HPV prophylactic vaccines","volume":"36","author":"Schiller","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.tvr.2022.200250_bib46","doi-asserted-by":"crossref","first-page":"e2211","DOI":"10.1093\/cid\/ciaa1456","article-title":"Human papillomavirus vaccination prior to loop electroexcision procedure does not prevent recurrent cervical high-grade squamous intraepithelial lesions in women living with human immunodeficiency virus: a randomized, double-blind, placebo-controlled trial","volume":"73","author":"Firnhaber","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tvr.2022.200250_bib47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2020.09.031","article-title":"Imiquimod for vaginal intraepithelial neoplasia 2-3: a systematic review and meta-analysis","volume":"160","author":"Inayama","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.tvr.2022.200250_bib48","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/ijc.30275","article-title":"Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management","volume":"139","author":"Tainio","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tvr.2022.200250_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/cancers14010063","article-title":"The impact of vulvar cancer on psychosocial and sexual functioning: a literature review","volume":"14","author":"Malandrone","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.tvr.2022.200250_bib50","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/ijgc-2021-003262","volume":"32","author":"Preti","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.tvr.2022.200250_bib51","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/S0140-6736(22)00469-X","article-title":"Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial","volume":"399","author":"Trutnovsky","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.tvr.2022.200250_bib53","article-title":"A prospective, dual-center trial of circumferential radiofrequency ablation of anal high-grade squamous intraepithelial lesions demonstrate improved long-term efficacy over historical controls of targeted ablation","author":"Goldstone","year":"2022","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.tvr.2022.200250_bib54","article-title":"Treatment options and outcomes for men with penile intraepithelial neoplasia: a systematic review","volume":"S2405\u20134569","author":"Issa","year":"2021","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.tvr.2022.200250_bib55","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jdcr.2017.07.018","article-title":"Combination of imiquimod with cryotherapy in the treatment of penile intraepithelial neoplasia","volume":"3","author":"Shaw","year":"2017","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.tvr.2022.200250_bib56","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.21.01785","article-title":"Absolute risk of oropharyngeal cancer after an HPV16-E6 serology test and potential implications for screening: results from the human papillomavirus cancer cohort consortium","author":"Robbins","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tvr.2022.200250_bib57","doi-asserted-by":"crossref","first-page":"E154","DOI":"10.1055\/a-1311-1014","article-title":"Structured oropharynx, hypopharynx and larynx assessment during routine esophagogastroduodenoscopy improves detection of pre- and early cancerous lesions: a multicenter, comparative study","volume":"9","author":"Huelsen","year":"2021","journal-title":"Endosc. Int. Open"}],"container-title":["Tumour Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679022000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679022000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:52:00Z","timestamp":1763005920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666679022000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":54,"alternative-id":["S2666679022000167"],"URL":"https:\/\/doi.org\/10.1016\/j.tvr.2022.200250","relation":{},"ISSN":["2666-6790"],"issn-type":[{"value":"2666-6790","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unresolved issues in the management of human papillomavirus-associated mucosal high-grade pre-cancers","name":"articletitle","label":"Article Title"},{"value":"Tumour Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvr.2022.200250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200250"}}